Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Single, Ascending Doses Of PF-05335810 In Hypercholesterolemic Subjects, With One, Open-Label, Multiple Fixed Dosage Cohort

NCT01720537 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01720537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01720537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Single, Ascending Doses Of PF-05335810 In Hypercholesterolemic Subjects, With One, Open-Label, Multiple Fixed Dosage Cohort
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2012
Completion date
October 31, 2013
Enrollment
133 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia